Annual EBIT
-$42.71 M
-$31.11 M-268.43%
31 December 2023
Summary:
Co-Diagnostics annual earnings before interest & taxes is currently -$42.71 million, with the most recent change of -$31.11 million (-268.43%) on 31 December 2023. During the last 3 years, it has fallen by -$84.40 million (-202.43%). CODX annual EBIT is now -192.71% below its all-time high of $46.40 million.CODX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.23 M
-$2.55 M-33.27%
30 September 2024
Summary:
Co-Diagnostics quarterly earnings before interest & taxes is currently -$10.23 million, with the most recent change of -$2.55 million (-33.27%) on 30 September 2024. Over the past year, it has dropped by -$1.30 million (-14.54%). CODX quarterly EBIT is now -163.85% below its all-time high of $16.03 million, reached on 31 December 2020.CODX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$40.00 M
-$1.30 M-3.36%
30 September 2024
Summary:
Co-Diagnostics TTM earnings before interest & taxes is currently -$40.00 million, with the most recent change of -$1.30 million (-3.36%) on 30 September 2024. Over the past year, it has increased by +$1.61 million (+3.88%). CODX TTM EBIT is now -175.31% below its all-time high of $53.11 million, reached on 31 March 2021.CODX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -268.4% | -14.5% | +3.9% |
| 3 y3 years | -202.4% | -175.1% | -177.2% |
| 5 y5 years | -595.9% | -485.6% | -543.5% |
CODX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -192.7% | at low | -175.1% | +14.7% | -177.2% | +7.0% |
| 5 y | 5 years | -192.7% | at low | -163.8% | +14.7% | -175.3% | +7.0% |
| alltime | all time | -192.7% | at low | -163.8% | +14.7% | -175.3% | +7.0% |
Co-Diagnostics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.23 M(+33.3%) | -$40.00 M(+3.4%) |
| June 2024 | - | -$7.68 M(-25.1%) | -$38.70 M(-10.0%) |
| Mar 2024 | - | -$10.26 M(-13.2%) | -$43.02 M(+0.7%) |
| Dec 2023 | -$42.71 M(+268.4%) | -$11.83 M(+32.3%) | -$42.71 M(+2.6%) |
| Sept 2023 | - | -$8.94 M(-25.5%) | -$41.61 M(+6.1%) |
| June 2023 | - | -$11.99 M(+20.5%) | -$39.21 M(+25.0%) |
| Mar 2023 | - | -$9.95 M(-7.3%) | -$31.37 M(+170.6%) |
| Dec 2022 | -$11.59 M(-125.2%) | -$10.73 M(+64.2%) | -$11.59 M(-222.7%) |
| Sept 2022 | - | -$6.54 M(+57.6%) | $9.45 M(-68.1%) |
| June 2022 | - | -$4.15 M(-142.2%) | $29.62 M(-35.0%) |
| Mar 2022 | - | $9.82 M(-4.7%) | $45.55 M(-1.1%) |
| Dec 2021 | $46.06 M(+10.5%) | $10.31 M(-24.4%) | $46.06 M(-11.0%) |
| Sept 2021 | - | $13.63 M(+15.6%) | $51.79 M(+3.2%) |
| June 2021 | - | $11.79 M(+14.1%) | $50.19 M(-5.5%) |
| Mar 2021 | - | $10.33 M(-35.5%) | $53.11 M(+27.4%) |
| Dec 2020 | $41.69 M | $16.03 M(+33.2%) | $41.69 M(+74.2%) |
| Sept 2020 | - | $12.04 M(-18.2%) | $23.93 M(+135.9%) |
| June 2020 | - | $14.71 M(-1459.5%) | $10.14 M(-271.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$1.08 M(-37.6%) | -$5.91 M(-3.0%) |
| Dec 2019 | -$6.09 M(-0.8%) | -$1.74 M(-0.7%) | -$6.09 M(-2.0%) |
| Sept 2019 | - | -$1.75 M(+30.0%) | -$6.22 M(+2.6%) |
| June 2019 | - | -$1.34 M(+6.5%) | -$6.06 M(-0.5%) |
| Mar 2019 | - | -$1.26 M(-32.2%) | -$6.09 M(-0.8%) |
| Dec 2018 | -$6.14 M(-7.7%) | -$1.86 M(+16.9%) | -$6.14 M(+6.2%) |
| Sept 2018 | - | -$1.59 M(+16.0%) | -$5.78 M(-28.3%) |
| June 2018 | - | -$1.37 M(+4.7%) | -$8.07 M(+9.1%) |
| Mar 2018 | - | -$1.31 M(-12.9%) | -$7.39 M(+11.2%) |
| Dec 2017 | -$6.65 M(+293.9%) | -$1.50 M(-61.2%) | -$6.65 M(+19.0%) |
| Sept 2017 | - | -$3.88 M(+453.3%) | -$5.59 M(+165.8%) |
| June 2017 | - | -$701.00 K(+24.2%) | -$2.10 M(+17.3%) |
| Mar 2017 | - | -$564.40 K(+26.9%) | -$1.79 M(-43.9%) |
| Dec 2016 | -$1.69 M(-14.2%) | -$444.60 K(+13.3%) | -$3.20 M(+16.2%) |
| Sept 2016 | - | -$392.40 K(+0.5%) | -$2.75 M(+16.6%) |
| June 2016 | - | -$390.30 K(-80.2%) | -$2.36 M(+19.8%) |
| Mar 2016 | - | -$1.97 M | -$1.97 M |
| Dec 2015 | -$1.97 M | - | - |
FAQ
- What is Co-Diagnostics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Co-Diagnostics?
- What is Co-Diagnostics annual EBIT year-on-year change?
- What is Co-Diagnostics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Co-Diagnostics?
- What is Co-Diagnostics quarterly EBIT year-on-year change?
- What is Co-Diagnostics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Co-Diagnostics?
- What is Co-Diagnostics TTM EBIT year-on-year change?
What is Co-Diagnostics annual earnings before interest & taxes?
The current annual EBIT of CODX is -$42.71 M
What is the all time high annual EBIT for Co-Diagnostics?
Co-Diagnostics all-time high annual earnings before interest & taxes is $46.40 M
What is Co-Diagnostics annual EBIT year-on-year change?
Over the past year, CODX annual earnings before interest & taxes has changed by -$31.11 M (-268.43%)
What is Co-Diagnostics quarterly earnings before interest & taxes?
The current quarterly EBIT of CODX is -$10.23 M
What is the all time high quarterly EBIT for Co-Diagnostics?
Co-Diagnostics all-time high quarterly earnings before interest & taxes is $16.03 M
What is Co-Diagnostics quarterly EBIT year-on-year change?
Over the past year, CODX quarterly earnings before interest & taxes has changed by -$1.30 M (-14.54%)
What is Co-Diagnostics TTM earnings before interest & taxes?
The current TTM EBIT of CODX is -$40.00 M
What is the all time high TTM EBIT for Co-Diagnostics?
Co-Diagnostics all-time high TTM earnings before interest & taxes is $53.11 M
What is Co-Diagnostics TTM EBIT year-on-year change?
Over the past year, CODX TTM earnings before interest & taxes has changed by +$1.61 M (+3.88%)